![Jing Rong Jean Cui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Rong Jean Cui
Founder at
BLOSSOMHILL THERAPEUTICS, INC.
Net worth: 73 M $ as of 30/08/2026
Profile
Jing Rong Jean Cui is the founder of Blossomhill Therapeutics, Inc., founded in 2020.
Dr. Jean Cui was the founder of Turning Point Therapeutics, Inc., founded in 2013, and held the title of Director in 2020.
Dr. Jean Cui earned a doctorate from The Ohio State University.
Dr. Jean Cui completed undergraduate and graduate degrees at the University of Science & Technology of China.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/08/2026 | 3,973,138 ( 12.97% ) | 73 M $ | 30/08/2026 |
Jing Rong Jean Cui active positions
| Companies | Position | Start |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Founder | 31/05/2020 |
Former positions of Jing Rong Jean Cui
| Companies | Position | End |
|---|---|---|
| TURG POIN | Founder | 14/06/2020 |
Training of Jing Rong Jean Cui
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
39
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Jing Rong Jean Cui
